Greenberg Traurig advised ALS Limited on the deal. ALS Limited (ALS) announced the acquisition of a 49 percent equity investment in Nuvisan Group (Nuvisan). Going forward, Nuvisan...
ALS’s Investment in Nuvisan
LivePerson’s Acquisition of e-bot7
Greenberg Traurig advised LivePerson, Inc. on the deal. YPOG advised the shareholders of e-bot7. Nasdaq-listed U.S. company LivePerson, Inc. (Nasdaq: LPSN) announced the acquisition of Munich-based startup...